- cafead   Aug 20, 2024 at 10:22: PM
via As House lawmakers prepare for a September vote on the controversial BIOSECURE Act, the House Select Committee on the CCP is expanding the scope of its scrutiny on China's biopharma ecosystem.
article source
article source